176 related articles for article (PubMed ID: 32419250)
21. Prognostic Value of BCL2 in Women Patients with Invasive Breast Cancer.
Ayadi EZ; Cherif B; Ben Hamed Y; Mokni M; Rebai A; Ayadi H; Jlidi R
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3557-3564. PubMed ID: 30583683
[TBL] [Abstract][Full Text] [Related]
22. Genes and functions from breast cancer signatures.
Huang S; Murphy L; Xu W
BMC Cancer; 2018 Apr; 18(1):473. PubMed ID: 29699511
[TBL] [Abstract][Full Text] [Related]
23. Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs.
Thomadaki H; Scorilas A
Connect Tissue Res; 2008; 49(3):261-4. PubMed ID: 18661356
[TBL] [Abstract][Full Text] [Related]
24. A long-range interactive DNA methylation marker panel for the promoters of HOXA9 and HOXA10 predicts survival in breast cancer patients.
Park SM; Choi EY; Bae M; Choi JK; Kim YJ
Clin Epigenetics; 2017; 9():73. PubMed ID: 28748001
[TBL] [Abstract][Full Text] [Related]
25. Promoter methylation reduces C/EBPdelta (CEBPD) gene expression in the SUM-52PE human breast cancer cell line and in primary breast tumors.
Tang D; Sivko GS; DeWille JW
Breast Cancer Res Treat; 2006 Jan; 95(2):161-70. PubMed ID: 16322893
[TBL] [Abstract][Full Text] [Related]
26. Pathway Relevance Ranking for Tumor Samples through Network-Based Data Integration.
Verbeke LP; Van den Eynden J; Fierro AC; Demeester P; Fostier J; Marchal K
PLoS One; 2015; 10(7):e0133503. PubMed ID: 26217958
[TBL] [Abstract][Full Text] [Related]
27. Prognostic influence of BCL2 expression in breast cancer.
Hwang KT; Woo JW; Shin HC; Kim HS; Ahn SK; Moon HG; Han W; Park IA; Noh DY
Int J Cancer; 2012 Oct; 131(7):E1109-19. PubMed ID: 22418857
[TBL] [Abstract][Full Text] [Related]
28. Prognostic, predictive abilities and concordance of BCL2 and TP53 protein expression in primary breast cancers and axillary lymph-nodes: a retrospective analysis of the Belgian three arm study evaluating anthracycline vs CMF adjuvant chemotherapy.
Bozovic-Spasojevic I; Ameye L; Paesmans M; Larsimont D; Di Leo A; Dolci S; Piccart M; de Azambuja E; Loi S
Breast; 2014 Aug; 23(4):473-81. PubMed ID: 24768477
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic regulation in human melanoma: past and future.
Sarkar D; Leung EY; Baguley BC; Finlay GJ; Askarian-Amiri ME
Epigenetics; 2015; 10(2):103-21. PubMed ID: 25587943
[TBL] [Abstract][Full Text] [Related]
30. Bcl2-low-expressing MCF7 cells undergo necrosis rather than apoptosis upon staurosporine treatment.
Poliseno L; Bianchi L; Citti L; Liberatori S; Mariani L; Salvetti A; Evangelista M; Bini L; Pallini V; Rainaldi G
Biochem J; 2004 May; 379(Pt 3):823-32. PubMed ID: 14748742
[TBL] [Abstract][Full Text] [Related]
31. The biological, clinical and prognostic implications of p53 transcriptional pathways in breast cancers.
Abdel-Fatah TM; Powe DG; Agboola J; Adamowicz-Brice M; Blamey RW; Lopez-Garcia MA; Green AR; Reis-Filho JS; Ellis IO
J Pathol; 2010 Mar; 220(4):419-34. PubMed ID: 20044801
[TBL] [Abstract][Full Text] [Related]
32. The immunoglobulin heavy-chain gene 3' enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells.
Duan H; Heckman CA; Boxer LM
Oncogene; 2007 Apr; 26(18):2635-41. PubMed ID: 17043638
[TBL] [Abstract][Full Text] [Related]
33. Expression of alpha B crystallin and BCL2 in patients with infiltrating ductal carcinoma.
Kim MS; Lee HW; Jun SY; Lee EH
Int J Clin Exp Pathol; 2015; 8(8):8842-56. PubMed ID: 26464626
[TBL] [Abstract][Full Text] [Related]
34. miR-1266-5p and miR-185-5p Promote Cell Apoptosis in Human Prostate Cancer Cell Lines.
Ostadrahimi S; Abedi Valugerdi M; Hassan M; Haddad G; Fayaz S; Parvizhamidi M; Mahdian R; Fard Esfahani P
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2305-2311. PubMed ID: 30141307
[TBL] [Abstract][Full Text] [Related]
35. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 gene family and related proteins in mammary gland involution and breast cancer.
Schorr K; Li M; Krajewski S; Reed JC; Furth PA
J Mammary Gland Biol Neoplasia; 1999 Apr; 4(2):153-64. PubMed ID: 10426394
[TBL] [Abstract][Full Text] [Related]
37. Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression.
Banas T; Pitynski K; Okon K; Winiarska A
BMC Cancer; 2018 Apr; 18(1):418. PubMed ID: 29653556
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
39. Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genes.
Papadopoulos EI; Yousef GM; Scorilas A
Biomed Pharmacother; 2015 Mar; 70():33-40. PubMed ID: 25776476
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
